Eight ‘NHS Genomic Networks of Excellence’ have been established as part of the NHS’s commitment to provide a world-leading NHS Genomic Medicine Service (GMS) which provides cutting-edge benefits for patients in the NHS.
The Networks (opens in a new tab) are developing evidence and models of adoption for cutting edge genomic advances and technology applications that will be transformative for patients. The NHS Genomic Networks of Excellence are designed to be partnerships between the NHS, academia, the third sector and industry to leverage expertise and resources from the broader genomics ecosystem, and to ensure there is a route towards rapid informing commissioning decisions.
The eight Genomic Networks of Excellence are:
- Prenatal genomic medicine (opens in a new tab)
- Circulating tumour biomarker testing (opens in a new tab)
- Haemato-oncology (opens in a new tab)
- Rare and inherited disease (opens in a new tab)
- Severe presentation of infectious disease (opens in a new tab)
- Cardiovascular disease (opens in a new tab)
- Pharmacogenomic and medicines optimisation (opens in a new tab)
- Genomics artificial intelligence (AI) (opens in a new tab)